References
- Kassell N F, Torner J C, Haley E C. The international cooperative study on the timing of aneurysm surgery. Part 1: overall management results. J Neurosurg 1990; 73: 18–36
- Ljunggren B, Brant L, Saveland H. Management of ruptured intracranial aneurysms: a review. Br J. Neurosurg 1987; 1: 9–32
- Muizelaar J P, Becker D P. Induced hypertension for the treatment of cerebral ischaemia after subarachnoid haemorrhage. Surg Neurol 1986; 25: 317–25
- Origitano T C, Wascher T M, Reichman O H. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (“Triple-H” therapy) after subarachnoid haemorrhage. Neurosurgery 1990; 27: 729–40
- Pickard J D, Murray G D, Illingworth R. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989; 298: 636–42
- Harders A, Gilsbach J M. Time course of blood velocity changes related to vasospasm in the circle of Willis measured by transcranial Doppler ultrasound. J Neurosurg 1987; 66: 718–28
- Messeter K, Brandt L, Ljunggren B. Prediction and prevention of delayed ischaemic dysfunction after aneurysmal subarachnoid haemorrhage and early operation. Neurosurgery 1987; 20: 548–53
- European CGRP Study Group. Effect of calcitonin gene related peptide in patients with delayed postoperative cerebral ischaemia after aneurysmal subarachnoid haemorrhage. Lancet 1992; 339(8797)831–4
- Taylor B, Harries P, Bullock R. Factors affecting outcome after surgery for intracranial aneurysm in Glasgow. Br J Neurosurg 1991; 5: 591–600
- Shaw M DM, Foy P M, Conway M. Dipyramidole and postoperative ischaemic deficits in aneurysmal subarachnoid haemorrhage. J Neurosurg 1985; 63: 699–703